Targeting molecular pathways in neuropathic cancer pain: from mechanisms to novel therapeutics

Published on March 5, 2026

iScience. 2026 Feb 10;29(3):114962. doi: 10.1016/j.isci.2026.114962. eCollection 2026 Mar 20.

ABSTRACT

Neuropathic cancer pain (NCP) remains a formidable clinical adversary, severely compromising the quality of life for cancer survivors. Its pathogenesis is highly complex and multifactorial, bifurcated into tumor-induced and chemotherapy-induced neuropathic pain. This review dissects the intricate molecular mechanism of NCP, highlighting how the tumor microenvironment orchestrates neuro-tumor interaction. Bridging the gap between pathogenesis and treatment, we evaluate the vanguard of therapeutic strategies designed to breach the current therapeutic impasse. We specifically explore the potential of antisense oligonucleotides in silencing pathological gene expression, the deployment of nanotechnology for bespoke drug delivery, the targets of neuro-tumor interactions, and the modulation of the endocannabinoid system as a novel analgesic target. In summary, by integrating pathogenic insights with therapeutic innovations, this review aims to catalyze a paradigm shift, from symptomatic management to mechanism-based precision intervention, paving the way for a new epoch in NCP management.

PMID:41782818 | PMC:PMC12955194 | DOI:10.1016/j.isci.2026.114962

Continue reading on website
Other news

Pain Neuroscience Education Versus Traditional Pain Education on Pain Attitudes and Beliefs of Physiotherapy Assistant Students: A Randomized-Controlled Trial

March 5, 2026
Physiother Res Int. 2026 Apr;31(2):e70187. doi: 10.1002/pri.70187.ABSTRACTBACKGROUND AND PURPOSE: Pain attitudes and beliefs of healthcare professionals play a crucial role in shaping treatment behaviors in pain management. Pain Neuroscience Education (PNE) frames pain as an output under the influence of biopsychosocial factors, rather than as a direct marker of tissue damage. This study aimed to

Internal neurolysis for atypical facial pain: Clinical outcomes and validation of an intraoperative trigeminal pathology scoring system

March 5, 2026
Surg Neurol Int. 2026 Jan 30;17:50. doi: 10.25259/SNI_1161_2025. eCollection 2026.ABSTRACTBACKGROUND: Atypical facial pain (AFP) differs from typical trigeminal neuralgia (TTN) in clinical features and pathophysiology. Internal neurolysis (IN) has been proposed as a treatment for refractory AFP; however, objective intraoperative assessment methods remain limited.METHODS: We retrospectively analyze